For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
|Articles|September 28, 2015
Andrew M. Kaunitz on Bioidentical Hormone Therapy
Author(s)Andrew M. Kaunitz
What is bioidentical hormone therapy? Andrew M. Kaunitz answers this important question.
Advertisement
Andrew M. Kaunitz, professor, Associate Chair, Department of Obstetrics and Gynecology, University of Florida College of Medicine — Jacksonville, describes bioidentical hormone therapy.
Advertisement
Related to this article
In the latest installment of CURE's "Text a Survivor" series, Brad Moore answers some of the most common questions people have about living with and beyond a colorectal cancer diagnosis.
Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after treatment.
Advertisement
Advertisement
Trending on CURE
1
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
2
My Sister and I Share a BRCA2 Mutation. We Didn’t Make the Same Choices
3
I’m Jealous of the World — and Grateful I Got to Be Part of It
4
We Eat Bagels Before Cancer Treatment. Here’s Why.
5